Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 2
2008 1
2009 3
2010 1
2011 3
2012 2
2013 3
2014 2
2015 1
2016 3
2017 3
2018 6
2019 6
2020 9
2021 14
2022 16
2023 17
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

80 results

Results by year

Filters applied: . Clear all
Page 1
Diagnostic Performance and Safety of Positron Emission Tomography with 18F-rhPSMA-7.3 in Patients with Newly Diagnosed Unfavourable Intermediate- to Very-high-risk Prostate Cancer: Results from a Phase 3, Prospective, Multicentre Study (LIGHTHOUSE).
Surasi DS, Eiber M, Maurer T, Preston MA, Helfand BT, Josephson D, Tewari AK, Somford DM, Rais-Bahrami S, Koontz BF, Bostrom PJ, Chau A, Davis P, Schuster DM, Chapin BF; LIGHTHOUSE Study Group. Surasi DS, et al. Among authors: somford dm. Eur Urol. 2023 Oct;84(4):361-370. doi: 10.1016/j.eururo.2023.06.018. Epub 2023 Jul 5. Eur Urol. 2023. PMID: 37414702 Free article.
Editorial comment.
Somford DM. Somford DM. J Urol. 2013 Sep;190(3):873. doi: 10.1016/j.juro.2013.03.129. Epub 2013 Jun 10. J Urol. 2013. PMID: 23763863 No abstract available.
Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer.
Tolmeijer SH, Boerrigter E, Sumiyoshi T, Kwan EM, Ng SWS, Annala M, Donnellan G, Herberts C, Benoist GE, Hamberg P, Somford DM, van Oort IM, Schalken JA, Mehra N, van Erp NP, Wyatt AW. Tolmeijer SH, et al. Among authors: somford dm. Clin Cancer Res. 2023 Aug 1;29(15):2835-2844. doi: 10.1158/1078-0432.CCR-22-2998. Clin Cancer Res. 2023. PMID: 36996325
Diffusion and perfusion MR imaging of the prostate.
Somford DM, Fütterer JJ, Hambrock T, Barentsz JO. Somford DM, et al. Magn Reson Imaging Clin N Am. 2008 Nov;16(4):685-95, ix. doi: 10.1016/j.mric.2008.07.002. Magn Reson Imaging Clin N Am. 2008. PMID: 18926431 Review.
Maintaining bone health by estrogen therapy in patients with advanced prostate cancer: a narrative review.
Coelingh Bennink HJT, Krijgh J, Egberts JFM, Slootweg M, van Melick HHE, Roos EPM, Somford DM, Zimmerman Y, Schultz IJ, Clarke NW, van Moorselaar RJA, Debruyne FMJ. Coelingh Bennink HJT, et al. Among authors: somford dm. Endocr Connect. 2022 Nov 18;11(12):e220182. doi: 10.1530/EC-22-0182. Print 2022 Dec 1. Endocr Connect. 2022. PMID: 36283120 Free PMC article. Review.
A Prospective Randomised Trial to Determine the Effect of a Reduced Versus Standard Dose of Enzalutamide on Side Effects in Frail Patients with Prostate Cancer.
Boerrigter E, Overbeek JK, Benoist GE, Somford DM, Hamberg P, Tol J, Scholtes B, Willemsen AECAB, Buffart LM, Kessels RPC, Mehra N, van Oort IM, van Erp NP. Boerrigter E, et al. Among authors: somford dm. Eur Urol Oncol. 2024 Mar 13:S2588-9311(24)00057-9. doi: 10.1016/j.euo.2024.02.009. Online ahead of print. Eur Urol Oncol. 2024. PMID: 38485614 Free article.
The Safety, Tolerability, and Preliminary Efficacy of a Gemcitabine-releasing Intravesical System (TAR-200) in American Urological Association-defined Intermediate-risk Non-muscle-invasive Bladder Cancer Patients: A Phase 1b Study.
P van Valenberg FJ, van der Heijden AG, Cutie CJ, Bhanvadia S, Keegan KA, Hampras S, Sweiti H, Maffeo JC, Jin S, Chau A, Reynolds DL, Iarossi C, Kelley A, Li X, Stromberg KA, Michiel Sedelaar JP, Steenbruggen JJO, Somford DM, Alfred Witjes J. P van Valenberg FJ, et al. Among authors: somford dm. Eur Urol Open Sci. 2024 Feb 16;62:8-15. doi: 10.1016/j.euros.2024.01.013. eCollection 2024 Apr. Eur Urol Open Sci. 2024. PMID: 38585206 Free PMC article.
Prostate-Specific Membrane Antigen-Targeted Radioguided Pelvic Lymph Node Dissection in Newly Diagnosed Prostate Cancer Patients with a Suspicion of Locoregional Lymph Node Metastases: The DETECT Trial.
Schilham MGM, Somford DM, Küsters-Vandevelde HVN, Hermsen R, van Basten JPA, Hoekstra RJ, Scheenen TWJ, Gotthardt M, Sedelaar JPM, Rijpkema M. Schilham MGM, et al. Among authors: somford dm. J Nucl Med. 2024 Mar 1;65(3):423-429. doi: 10.2967/jnumed.123.266495. J Nucl Med. 2024. PMID: 38176721 Clinical Trial.
80 results